Literature DB >> 15018834

Metabotropic glutamate 2/3 receptors as drug targets.

Gerard J Marek1.   

Abstract

Metabotropic glutamate receptors are a family of class III G-protein-coupled receptors comprising eight members (mGluR1-8), which are an attractive target in the central nervous system because of the widespread use of glutamate as the principal excitatory amino acid transmitter. The unique pharmacology of class III G-protein coupled receptors, their forebrain localization in key limbic-related cortical/thalamic/striatal/amygdaloid circuits, and the promise of subtle modulation of glutamatergic neurotransmission make these receptors intriguing targets for a wide variety of neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018834     DOI: 10.1016/j.coph.2003.10.003

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  24 in total

1.  Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

Authors:  José L Moreno; Terrell Holloway; Laura Albizu; Stuart C Sealfon; Javier González-Maeso
Journal:  Neurosci Lett       Date:  2011-01-27       Impact factor: 3.046

2.  The Drosophila metabotropic glutamate receptor DmGluRA regulates activity-dependent synaptic facilitation and fine synaptic morphology.

Authors:  Laurent Bogdanik; Ralf Mohrmann; Ariane Ramaekers; Joël Bockaert; Yves Grau; Kendal Broadie; Marie-Laure Parmentier
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

3.  Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.

Authors:  José L Moreno; Mitsumasa Kurita; Terrell Holloway; Javier López; Richard Cadagan; Luis Martínez-Sobrido; Adolfo García-Sastre; Javier González-Maeso
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

4.  Radiosynthesis of PET radiotracer as a prodrug for imaging group II metabotropic glutamate receptors in vivo.

Authors:  Ji-Quan Wang; Zhaoda Zhang; Darshini Kuruppu; Anna-Liisa Brownell
Journal:  Bioorg Med Chem Lett       Date:  2012-01-21       Impact factor: 2.823

5.  The metabotropic glutamate 2/3 receptor agonist LY379268 counteracted ketamine-and apomorphine-induced performance deficits in the object recognition task, but not object location task, in rats.

Authors:  Nikolaos Pitsikas; Athina Markou
Journal:  Neuropharmacology       Date:  2014-05-20       Impact factor: 5.250

Review 6.  From synapse to nucleus: novel targets for treating depression.

Authors:  Herbert E Covington; Vincent Vialou; Eric J Nestler
Journal:  Neuropharmacology       Date:  2009-12-17       Impact factor: 5.250

Review 7.  Metabotropic glutamate receptor ligands as potential therapeutics for addiction.

Authors:  M Foster Olive
Journal:  Curr Drug Abuse Rev       Date:  2009-01

8.  Impaired expression and function of group II metabotropic glutamate receptors in pilocarpine-treated chronically epileptic rats.

Authors:  Emilio R Garrido-Sanabria; Luis F Pacheco Otalora; Massoud F Arshadmansab; Berenice Herrera; Sebastian Francisco; Boris S Ermolinsky
Journal:  Brain Res       Date:  2008-09-10       Impact factor: 3.252

9.  Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.

Authors:  Takaki Kiritoshi; Volker Neugebauer
Journal:  Neuropharmacology       Date:  2015-04-22       Impact factor: 5.250

10.  The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats.

Authors:  Xia Li; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2007-11-19       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.